KCNJ10 (also known as Kir4.1) is a critical inwardly rectifying potassium channel that plays essential roles in glial cell function and neuronal homeostasis in the brain. This gene encodes the Kir4.1 potassium channel, which is predominantly expressed in astrocytes and oligodendrocytes throughout the central nervous system. Kir4.1 is crucial for maintaining the resting membrane potential, buffering extracellular potassium during neuronal activity, and supporting myelin maintenance. Dysfunction of KCNJ10 has been implicated in various neurological disorders including epilepsy, ataxia, sensorineural deafness, and multiple sclerosis.
KCNJ10 (also known as Kir4.1) is a critical inwardly rectifying potassium channel that plays essential roles in glial cell function and neuronal homeostasis in the brain. This gene encodes the Kir4.1 potassium channel, which is predominantly expressed in astrocytes and oligodendrocytes throughout the central nervous system. Kir4.1 is crucial for maintaining the resting membrane potential, buffering extracellular potassium during neuronal activity, and supporting myelin maintenance. Dysfunction of KCNJ10 has been implicated in various neurological disorders including epilepsy, ataxia, sensorineural deafness, and multiple sclerosis.
<div class="infobox infobox-gene"> [@hibino2010]
<table> [@tanemoto2009]
<tr><th colspan="2" style="background:#e8f4ea;">KCNJ10 Gene</th></tr> [@kofuji2004]
<tr><td><b>Full Name</b></td><td>Potassium Inwardly Rectifying Channel Subfamily J Member 10 (Kir4.1)</td></tr> [@djukic2007]
<tr><td><b>Chromosome</b></td><td>1q23.2</td></tr> [@schirmer2018]
<tr><td><b>NCBI Gene ID</b></td><td>[3766](https://www.ncbi.nlm.nih.gov/gene/3766)</td></tr> [@zhang2014]
<tr><td><b>OMIM</b></td><td>[602208](https://www.omim.org/entry/602208)</td></tr> [@bockenhauer2009]
<tr><td><b>Ensembl ID</b></td><td>ENSG00000177853</td></tr> [@scholl2009]
<tr><td><b>UniProt ID</b></td><td>[P48169](https://www.uniprot.org/uniprot/P48169)</td></tr> [@srivastava2012]
<tr><td><b>Associated Diseases</b></td><td>Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability (SESAME syndrome), EAST syndrome, Multiple sclerosis</td></tr> [@dhaeseleer2015]
</table> [@liao2018]
</div> [@verdile2004]
KCNJ10 encodes Kir4.1, an inwardly rectifying potassium channel expressed primarily in glial cells ([astrocytes](/entities/astrocytes) and [oligodendrocytes](/entities/oligodendrocytes)) and certain [neurons](/entities/neurons). Kir4.1 is crucial for maintaining the resting membrane potential, potassium buffering in the brain, and myelin maintenance. Mutations cause seizures and sensorineural deafness, and Kir4.1 dysfunction has been implicated in multiple sclerosis and epilepsy. [@chen2015]
The KCNJ10 gene spans approximately 4.5 kb and consists of 4 exons that encode a protein of 379 amino acids. The Kir4.1 protein contains two transmembrane domains (M1 and M2), a pore loop (P-loop) containing the K+ selectivity filter (GYG motif), and intracellular N- and C-termini that contain regulatory domains [1][2]. The channel forms a tetrameric structure, with each subunit contributing to the central pore. The intracellular C-terminus contains binding sites for phosphatidylinositol 4,5-bisphosphate (PIP2), which is required for channel activity, and regulatory proteins including the sulfonylurea receptor (SUR1) in some contexts [3]. [@whitton2015]
Kir4.1 channels play a critical role in maintaining potassium homeostasis in the brain. During neuronal activity, neurons release potassium into the extracellular space. Astrocytic Kir4.1 channels uptake this excess potassium, preventing extracellular K+ accumulation that could lead to neuronal hyperexcitability and seizures [4]. This potassium buffering function is essential for:
Kir4.1 channels are functionally coupled with glutamate transporters (particularly EAAT1/GLAST and EAAT2/GLT-1) on astrocytes. The channel's activity helps maintain the driving force for glutamate uptake by keeping the astrocyte membrane potential negative [5]. Dysfunction of this coupling can lead to impaired glutamate clearance, excitotoxicity, and neuronal death—mechanisms central to neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).
In oligodendrocytes, Kir4.1 channels are essential for maintaining myelin integrity. The channel helps regulate the intracellular potassium concentration in oligodendrocyte precursor cells (OPCs) and mature oligodendrocytes, which is necessary for proper myelination [6]. Loss of Kir4.1 function leads to hyperexcitability, vacuolization, and degeneration of white matter—pathological features observed in multiple sclerosis and leukodystrophies.
Expression of KCNJ10 is detected throughout the brain with particular enrichment in:
Biallelic loss-of-function mutations in KCNJ10 cause a rare autosomal recessive disorder characterized by:
Multiple lines of evidence implicate Kir4.1 dysfunction in multiple sclerosis:
Kir4.1 dysfunction contributes to epilepsy through:
In [Alzheimer's disease](/diseases/alzheimers-disease), Kir4.1 dysfunction may contribute to:
In [Parkinson's disease](/diseases/parkinsons-disease):
Several therapeutic strategies targeting Kir4.1 are under investigation:
Circulating Kir4.1 autoantibodies may serve as biomarkers for:
Ongoing research focuses on:
The study of Kcnj10 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
KCNJ10 (also known as Kir4.1 or inward-rectifier potassium channel 4) is a member of the inward-rectifier potassium channel family (Kir). These channels allow potassium ions to flow more easily into the cell than out, playing crucial roles in maintaining cellular resting membrane potential and regulating excitability.
Key molecular functions include:
KCNJ10 mutations cause epilepsy syndromes:
KCNJ10 dysfunction may contribute to AD pathogenesis:
KCNJ10 as a therapeutic target:
KCNJ10 participates in several key pathways:
The following diagram shows the key molecular relationships involving KCNJ10 Gene discovered through SciDEX knowledge graph analysis: